Rare diseases
Investigational molecules
Locations
Durvalumab versus standard chemotherapy drug combination in elderly patients with advanced non‑small cell lung cancer
ItalyGedatolisib plus drug combination for HR‑positive, HER2‑negative advanced breast cancer patients whose disease progressed after CDK4/6 inhibitor therapy
ItalyStudy of Trontinemab Compared to Placebo for Patients with Early Symptomatic Alzheimer's Disease
ItalyA study testing trontinemab compared to placebo in patients with early Alzheimer's disease including mild cognitive impairment and mild dementia
ItalyA Study to Test the Long-term Safety and Benefits of GSK4527226 in Patients with Early Alzheimer's Disease
ItalyStudy of ABBV-CLS-628 to evaluate safety and effectiveness in adults with Autosomal Dominant Polycystic Kidney Disease
ItalyStudy on the Effects of CAL101 for Patients with Idiopathic Pulmonary Fibrosis
ItalyStudy on the Effects of Remibrutinib for Adults with Moderate to Severe Hidradenitis Suppurativa
ItalyStudy on the Safety and Effectiveness of CSL889 for Adults and Adolescents with Sickle Cell Disease During Painful Crises
ItalyStudy to Test if Nerandomilast (BI 1015550) Helps Patients with Interstitial Lung Disease Related to Rheumatic Diseases
ItalyStudy on the Effectiveness and Safety of Sonrotoclax and Zanubrutinib for Adults with Untreated Chronic Lymphocytic Leukemia
ItalyStudy on the Effectiveness and Safety of Datopotamab Deruxtecan Compared to Chemotherapy in Adults with Advanced Triple-negative Breast Cancer
ItalyTell us about your condition – we search every trial in Europe and connect you with the right site.
